PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.

Biotechnology

PEP-Therapy

Antoine Prestat

Michele Marzola

Jennifer Sengenès

Laura Dadon

The Scientific Advisory Team at PEP-Therapy provides expert guidance on the development and optimization of the company's innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology. They advise on research strategies, clinical trial design, and regulatory considerations to advance targeted oncology therapies.

Scientific Advisory Team

About

Team members